Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Youth With SUD and Severe Mood Dysregulation
NCT02845453Phase 4Completed
- Sponsor
- Boston Medical Center
- Start
- Jan 2017
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in substance use disorder (SUD), bipolar disorder (BD), disruptive mood dysregulation disorder (DMDD), mood disorder, sponsored by Boston Medical Center. Started Jan 2017; status: completed.
02
Drugs
quetiapine
03
Conditions
substance use disorder (SUD)bipolar disorder (BD)disruptive mood dysregulation disorder (DMDD)mood disorder
Beyond the preview
Go deeper on NCT02845453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02845453.